Copyright Reports & Markets. All rights reserved.

Global Analgesic and Anti-inflammatory API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Analgesic and Anti-inflammatory API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Analgesic and Anti-inflammatory API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Ibuprofen
    • 1.3.3 Paracetamol
    • 1.3.4 Aspirin
    • 1.3.5 Naproxen
    • 1.3.6 Diclofenac
    • 1.3.7 Oxaprozin
    • 1.3.8 Dexibuprofen
    • 1.3.9 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Analgesic and Anti-inflammatory API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Adults
    • 1.4.3 Children
  • 1.5 Global Analgesic and Anti-inflammatory API Market Size & Forecast
    • 1.5.1 Global Analgesic and Anti-inflammatory API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Analgesic and Anti-inflammatory API Sales Quantity (2018-2029)
    • 1.5.3 Global Analgesic and Anti-inflammatory API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 IOL
    • 2.1.1 IOL Details
    • 2.1.2 IOL Major Business
    • 2.1.3 IOL Analgesic and Anti-inflammatory API Product and Services
    • 2.1.4 IOL Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 IOL Recent Developments/Updates
  • 2.2 Mallinckrodt Pharmaceuticals
    • 2.2.1 Mallinckrodt Pharmaceuticals Details
    • 2.2.2 Mallinckrodt Pharmaceuticals Major Business
    • 2.2.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product and Services
    • 2.2.4 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
  • 2.3 Anqiu Lu'an Pharmaceutical
    • 2.3.1 Anqiu Lu'an Pharmaceutical Details
    • 2.3.2 Anqiu Lu'an Pharmaceutical Major Business
    • 2.3.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
    • 2.3.4 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Anqiu Lu'an Pharmaceutical Recent Developments/Updates
  • 2.4 Novacyl
    • 2.4.1 Novacyl Details
    • 2.4.2 Novacyl Major Business
    • 2.4.3 Novacyl Analgesic and Anti-inflammatory API Product and Services
    • 2.4.4 Novacyl Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Novacyl Recent Developments/Updates
  • 2.5 BASF
    • 2.5.1 BASF Details
    • 2.5.2 BASF Major Business
    • 2.5.3 BASF Analgesic and Anti-inflammatory API Product and Services
    • 2.5.4 BASF Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 BASF Recent Developments/Updates
  • 2.6 BBCA Group
    • 2.6.1 BBCA Group Details
    • 2.6.2 BBCA Group Major Business
    • 2.6.3 BBCA Group Analgesic and Anti-inflammatory API Product and Services
    • 2.6.4 BBCA Group Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 BBCA Group Recent Developments/Updates
  • 2.7 Hubei Biocause Group
    • 2.7.1 Hubei Biocause Group Details
    • 2.7.2 Hubei Biocause Group Major Business
    • 2.7.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Product and Services
    • 2.7.4 Hubei Biocause Group Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Hubei Biocause Group Recent Developments/Updates
  • 2.8 Xinhua Pharm
    • 2.8.1 Xinhua Pharm Details
    • 2.8.2 Xinhua Pharm Major Business
    • 2.8.3 Xinhua Pharm Analgesic and Anti-inflammatory API Product and Services
    • 2.8.4 Xinhua Pharm Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Xinhua Pharm Recent Developments/Updates
  • 2.9 Granules India Limited
    • 2.9.1 Granules India Limited Details
    • 2.9.2 Granules India Limited Major Business
    • 2.9.3 Granules India Limited Analgesic and Anti-inflammatory API Product and Services
    • 2.9.4 Granules India Limited Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Granules India Limited Recent Developments/Updates
  • 2.10 Hebei Jiheng Pharmaceutical
    • 2.10.1 Hebei Jiheng Pharmaceutical Details
    • 2.10.2 Hebei Jiheng Pharmaceutical Major Business
    • 2.10.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
    • 2.10.4 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
  • 2.11 Zhejiang Kangle Pharmaceutical
    • 2.11.1 Zhejiang Kangle Pharmaceutical Details
    • 2.11.2 Zhejiang Kangle Pharmaceutical Major Business
    • 2.11.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
    • 2.11.4 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
  • 2.12 Hunan Zhongnan Pharmaceutical
    • 2.12.1 Hunan Zhongnan Pharmaceutical Details
    • 2.12.2 Hunan Zhongnan Pharmaceutical Major Business
    • 2.12.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product and Services
    • 2.12.4 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
  • 2.13 Hebei Jingye Medical Technology
    • 2.13.1 Hebei Jingye Medical Technology Details
    • 2.13.2 Hebei Jingye Medical Technology Major Business
    • 2.13.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product and Services
    • 2.13.4 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Hebei Jingye Medical Technology Recent Developments/Updates

3 Competitive Environment: Analgesic and Anti-inflammatory API by Manufacturer

  • 3.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Analgesic and Anti-inflammatory API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Analgesic and Anti-inflammatory API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Analgesic and Anti-inflammatory API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Analgesic and Anti-inflammatory API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Analgesic and Anti-inflammatory API Manufacturer Market Share in 2022
  • 3.5 Analgesic and Anti-inflammatory API Market: Overall Company Footprint Analysis
    • 3.5.1 Analgesic and Anti-inflammatory API Market: Region Footprint
    • 3.5.2 Analgesic and Anti-inflammatory API Market: Company Product Type Footprint
    • 3.5.3 Analgesic and Anti-inflammatory API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Analgesic and Anti-inflammatory API Market Size by Region
    • 4.1.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Analgesic and Anti-inflammatory API Average Price by Region (2018-2029)
  • 4.2 North America Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
  • 4.3 Europe Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
  • 4.5 South America Analgesic and Anti-inflammatory API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Analgesic and Anti-inflammatory API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
  • 5.2 Global Analgesic and Anti-inflammatory API Consumption Value by Type (2018-2029)
  • 5.3 Global Analgesic and Anti-inflammatory API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
  • 6.2 Global Analgesic and Anti-inflammatory API Consumption Value by Application (2018-2029)
  • 6.3 Global Analgesic and Anti-inflammatory API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
  • 7.2 North America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
  • 7.3 North America Analgesic and Anti-inflammatory API Market Size by Country
    • 7.3.1 North America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Analgesic and Anti-inflammatory API Market Size by Country
    • 8.3.1 Europe Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Analgesic and Anti-inflammatory API Market Size by Region
    • 9.3.1 Asia-Pacific Analgesic and Anti-inflammatory API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Analgesic and Anti-inflammatory API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
  • 10.2 South America Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
  • 10.3 South America Analgesic and Anti-inflammatory API Market Size by Country
    • 10.3.1 South America Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Analgesic and Anti-inflammatory API Market Size by Country
    • 11.3.1 Middle East & Africa Analgesic and Anti-inflammatory API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Analgesic and Anti-inflammatory API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Analgesic and Anti-inflammatory API Market Drivers
  • 12.2 Analgesic and Anti-inflammatory API Market Restraints
  • 12.3 Analgesic and Anti-inflammatory API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Analgesic and Anti-inflammatory API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Analgesic and Anti-inflammatory API
  • 13.3 Analgesic and Anti-inflammatory API Production Process
  • 13.4 Analgesic and Anti-inflammatory API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Analgesic and Anti-inflammatory API Typical Distributors
  • 14.3 Analgesic and Anti-inflammatory API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Analgesic and Anti-inflammatory API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Analgesics, also called painkillers, are medications that relieve different types of pain — from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain.
    This report is a detailed and comprehensive analysis for global Analgesic and Anti-inflammatory API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Analgesic and Anti-inflammatory API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
    Global Analgesic and Anti-inflammatory API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
    Global Analgesic and Anti-inflammatory API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
    Global Analgesic and Anti-inflammatory API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Analgesic and Anti-inflammatory API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Analgesic and Anti-inflammatory API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IOL, Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical, Novacyl and BASF, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Analgesic and Anti-inflammatory API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Ibuprofen
    Paracetamol
    Aspirin
    Naproxen
    Diclofenac
    Oxaprozin
    Dexibuprofen
    Others
    Market segment by Application
    Adults
    Children
    Major players covered
    IOL
    Mallinckrodt Pharmaceuticals
    Anqiu Lu'an Pharmaceutical
    Novacyl
    BASF
    BBCA Group
    Hubei Biocause Group
    Xinhua Pharm
    Granules India Limited
    Hebei Jiheng Pharmaceutical
    Zhejiang Kangle Pharmaceutical
    Hunan Zhongnan Pharmaceutical
    Hebei Jingye Medical Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Analgesic and Anti-inflammatory API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Analgesic and Anti-inflammatory API, with price, sales, revenue and global market share of Analgesic and Anti-inflammatory API from 2018 to 2023.
    Chapter 3, the Analgesic and Anti-inflammatory API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Analgesic and Anti-inflammatory API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Analgesic and Anti-inflammatory API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Analgesic and Anti-inflammatory API.
    Chapter 14 and 15, to describe Analgesic and Anti-inflammatory API sales channel, distributors, customers, research findings and conclusion.

    Buy now